Home
»
Projects
»
HIV
»
HIV - Apricitabine
HIV - Apricitabine
Home
Corporate
Company Overview
Business Development
People
Corporate Governance
Avexa Employee Share Option Plan
Projects
HCV
HIV
Scientific Collaborations
VRI
Clinical Trials
AVX 101 and AVX 102 Posters
AVX-201 Trial
News
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Investor Relations
Company Reports
Prospectus 2007
Shareholder Newsletters
Analyst Reports
Presentations
Poster XV11 HIV Drug Resistance Workshop June 2008
Investor Presentation March 2008
BIO CEO Investor Conference New York February 2008
CROI Poster Boston 2008
CEO Presentation AGM 2007
Investor Presentation October 2007
Investor Roadshow Presentation 2007
Presentation by Dr Cahn IAS Conference July 2007
Investor Roadshow Presentation March 2007
HIV Glasgow Conference November 2006 Apricitabine Poster
AGM CEO presentation 2006
Investor Roadshow Presentation November 2006
FAQs
Avexa Demerger
General
Annual Report Information
Shareholder Information
Contact Us
Contact Form
Careers
Search
Site Map